About Starlight Cardiovascular
Starlight Cardiovascular is a Healthcare company based in San Diego (United States) founded in 2020 by Tom Duerig, Attila Meretei, Pedro del Nido, and Carl Berke. Devices for treating pediatric congenital heart defects are manufactured. Starlight Cardiovascular has raised $9.48 million across 5 funding rounds from investors including HHS, Bird B and MedTech Innovator. The company has 8 employees. Its focus areas include Life Sciences, Pediatrics, Medical Devices and Therapeutics. Its legal entity is STARLIGHT CARDIOVASCULAR INC. Its competitors include PECA Labs, Bolder Surgical and PolyVascular; 3 of its 3 listed competitors have raised funding.
Company details
Starlight Cardiovascular was founded in 2020 in San Diego, United States. Medical devices targeted at pediatric congenital heart defects are developed and produced by the company within the cardiovascular sector. Operations emphasize manufacturing processes for these specialized treatments. Co-founders Tom Duerig, Attila Meretei, Pedro del Nido, and Carl Berke guide the firms activities in this niche medical field.
- Headquarters San Diego, United States
- Employees 8
- Founders Tom Duerig, Attila Meretei, Pedro del Nido, Carl Berke
- SectorsHealthcare
- Email••••••••
- Website starlightcardio.com
- Social LinkedIn
- Legal Name Starlight Cardiovascular Inc
- Total Equity Funding$9.48M (USD)
in 5 rounds
- Latest Funding Round$500K (USD), Grant
Sep 2024
- InvestorsHHS
& 2 more
- Employee Count8
Funding Insights of Starlight Cardiovascular
Starlight Cardiovascular has successfully raised a total of $9.48M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $500 thousand completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $9.48M
- Total Rounds 5
- Last Round Grant — $500,000
- First Round $3.65M
(Aug 2021)
- Investors Count 3
All 5 funding rounds of Starlight Cardiovascular with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2024 | $500,000 | Grant | – | – | |
| Oct 2022 | $9.48M | Series A | – | BIRD B | – |
| Feb 2022 | $1.54M | Grant | – | – | |
| Dec 2021 | $150,000 | Grant | – | – | |
| Aug 2021 | $3.65M | Grant | – | – |
3 investors in total: 3 institutional.
Investors in Starlight Cardiovascular
Starlight Cardiovascular has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Bird B and MedTech Innovator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Bird B. AG is engaged in medical technology investments. | 2003 | bird-b.com | Schaffhausen, Switzerland | |
Acceleration of medical device, digital health, and diagnostic companies is facilitated worldwide. | medtechinnovator.org | |||
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Starlight Cardiovascular
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Starlight Cardiovascular
6 people are tracked at Starlight Cardiovascular (6 in leadership); the tracked headcount is 8.
| Name | Role | Group |
|---|---|---|
Tom Duerig | Co-Founder | Leadership |
Attila Meretei | Co-Founder | Leadership |
Pedro del Nido | Co-Founder | Leadership |
Carl Berke | Co-Founder | Leadership |
Beverly Tang | Chief Executive Officer | Leadership |
Kathryn Olson | VP of Strategic & Product Marketing | Leadership |
Complete people profiles for Starlight Cardiovascular
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Starlight Cardiovascular
3 dated milestones of Starlight Cardiovascular across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Starlight Cardiovascular is founded.
- Funding First funding round of $3.7M.
- Funding Latest funding round, Grant, of $500K.
Competitors of Starlight Cardiovascular
Starlight Cardiovascular has 3 listed competitors in our database, 3 of them funded. They include PECA Labs, Bolder Surgical and PolyVascular.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pecalabs.com | 2011 | Pittsburgh, United States | $19.91M | Pediatric cardiac surgical devices are developed for congenital heart defects. | ||
| boldersurgical.com | 2010 | Louisville, United States | $58.87M | Developer of electrosurgical device for pediatric patients | ||
| polyvascular.com | 2014 | Houston, United States | $795,000 | Polymeric transcatheter valves are developed for congenital heart disease treatment. |
Detailed competitors of Starlight Cardiovascular
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pediatrics
3 companies that operate in the same segment as Starlight Cardiovascular (Pediatrics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Owlet is recognized for developing FDA-cleared smart baby monitors. | 2013 | Lehi, Utah, United States | USD 54.96 M | USD 105.71 M | 85 | |
Therapeutics for gastrointestinal disorders, including linaclotide, are developed. | 1998 | Cambridge, Massachusetts, United States | USD 206.25 M | USD 296.15 M | 253 | |
Smart baby monitors and sleep tracking solutions are provided. | 2014 | New York, New York, United States | USD 116.6 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Starlight Cardiovascular
Complete news archive for Starlight Cardiovascular
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Starlight Cardiovascular
Starlight Cardiovascular was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Starlight Cardiovascular is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Starlight Cardiovascular is a funded company, having raised a total of $9.48M across 5 funding rounds to date. The company's 1st funding round was a Grant of $3.65M, raised on Aug 2021.
Starlight Cardiovascular has 8 employees.
Starlight Cardiovascular was founded in 2020 in San Diego, United States. Medical devices targeted at pediatric congenital heart defects are developed and produced by the company within the cardiovascular sector. Operations emphasize manufacturing processes for these specialized treatments. Co-founders Tom Duerig, Attila Meretei, Pedro del Nido, and Carl Berke guide the firms activities in this niche medical field.
Starlight Cardiovascular's top competitors include PECA Labs, Bolder Surgical and PolyVascular.
Starlight Cardiovascular has 3 investors. Key investors include HHS, Bird B, and MedTech Innovator.
Starlight Cardiovascular operates through Starlight Cardiovascular Inc.